Catalyst Wire Dossier Catalyst Wire Dossier

Idarucizumab

idarucizumab · Boehringer Ingelheim
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for Idarucizumab, covering 2017-08-18 to 2021-08-20. Get the full timeline:

Most recent: Clinical Trial Update: This Study Looks at the Effects of Idarucizumab in Patients Who Take Dabigatran and Need Emergency Surgery or Are Bleeding [Phase 3]

See pricing